Skip to main content

Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week

The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.